Citigroup Inc Co Diagnostics, Inc. Transaction History
Citigroup Inc
- $190 Billion
- Q1 2025
A detailed history of Citigroup Inc transactions in Co Diagnostics, Inc. stock. As of the latest transaction made, Citigroup Inc holds 294 shares of CODX stock, worth $91. This represents 0.0% of its overall portfolio holdings.
Number of Shares
294Holding current value
$91% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CODX
# of Institutions
43Shares Held
5.72MCall Options Held
35.6KPut Options Held
25.9K-
Vanguard Group Inc Valley Forge, PA1.78MShares$551,2360.0% of portfolio
-
Private Advisory Group LLC Redmond, WA1.18MShares$366,3060.04% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny550KShares$170,5990.0% of portfolio
-
Black Rock Inc. New York, NY502KShares$155,6270.0% of portfolio
-
Geode Capital Management, LLC Boston, MA342KShares$106,0720.0% of portfolio
About Co-Diagnostics, Inc.
- Ticker CODX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 33,781,000
- Market Cap $10.5M
- Description
- Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...